UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 506

Sortiert nach

Poly (ADP-ribose) polymerase inhibitors: recent advances and future development

Journal of clinical oncology, 2015-04, Vol.33 (12), p.1397-1406

2015

Volltextzugriff (PDF)

Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells

Proceedings of the National Academy of Sciences - PNAS, 2011-02, Vol.108 (8), p.3406-3411

2011

Volltextzugriff (PDF)

FAM111A protects replication forks from protein obstacles via its trypsin-like domain

Nature communications, 2020-03, Vol.11 (1), p.1318-1318, Article 1318

2020

Volltextzugriff (PDF)

Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase In Vitro

Clinical cancer research, 2012-03, Vol.18 (6), p.1655-1662

2012

Volltextzugriff (PDF)

Characterization of an alternative BAK-binding site for BH3 peptides

Nature communications, 2020-07, Vol.11 (1), p.1-14, Article 3301

2020

Volltextzugriff (PDF)

Evaluation of the BH3-only Protein Puma as a Direct Bak Activator

The Journal of biological chemistry, 2014-01, Vol.289 (1), p.89-99

2014

Volltextzugriff (PDF)

ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (12), p.3683-3691

2013

Volltextzugriff (PDF)

A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice

Nature communications, 2016-01, Vol.7 (1), p.10201-10201, Article 10201

2016

Volltextzugriff (PDF)

COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A

Molecular biology of the cell, 2015-01, Vol.26 (1), p.91-103

2015

Volltextzugriff (PDF)

The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer

Clinical cancer research, 2020-07, Vol.26 (13), p.3397-3407

2020

Volltextzugriff (PDF)

Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2

PLoS pathogens, 2020-10, Vol.16 (10), p.e1008906-e1008906

2020

Volltextzugriff (PDF)

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

Cancers, 2021-12, Vol.13 (24), p.6385

2021

Volltextzugriff (PDF)

Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response

Scientific reports, 2023-01, Vol.13 (1), p.730-18, Article 730

2023

Volltextzugriff (PDF)

How does doxorubicin work?

eLife, 2012-12, Vol.1, p.e00387-e00387

2012

Volltextzugriff (PDF)

Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization

The Journal of cell biology, 2011-07, Vol.194 (1), p.39-48

2011

Volltextzugriff (PDF)

Topoisomerases and cancer chemotherapy: recent advances and unanswered questions [version 1; peer review: 3 approved]

F1000 research, 2019, Vol.8, p.1704

2019

Volltextzugriff (PDF)

Eltrombopag directly activates BAK and induces apoptosis

Cell death & disease, 2023-07, Vol.14 (7), p.394-394, Article 394

2023

Volltextzugriff (PDF)

ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance

Nucleic acids research, 2023-11, Vol.51 (20), p.11056

2023

Volltextzugriff (PDF)

DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer

BMC bioinformatics, 2022-08, Vol.23 (1), p.321-321, Article 321

2022

Volltextzugriff (PDF)

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

Cell death & disease, 2021-10, Vol.12 (11), p.977-977, Article 977

2021

Volltextzugriff (PDF)

Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

Blood, 2009-10, Vol.114 (14), p.2926-2935

2009

Volltextzugriff (PDF)

Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes

The Journal of biological chemistry, 2012-02, Vol.287 (6), p.4198-4210

2012

Volltextzugriff (PDF)

Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma

Journal of hepatology, 2018-06, Vol.68 (6), p.1228-1238

2018

Volltextzugriff (PDF)

Immunodetection of human topoisomerase I-DNA covalent complexes

Nucleic acids research, 2016-04, Vol.44 (6), p.2816

2016

Volltextzugriff (PDF)

1 – 25 von 506

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(485)
Mit Volltextzugriff
(479)

Publikationsform

Sprache

Englisch
(504)
Japanisch
(96)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Poly (ADP-ribose) polymerase inhibitors: recent advances and future development

Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

FAM111A protects replication forks from protein obstacles via its trypsin-like domain

Failure of Iniparib to Inhibit Poly(ADP-Ribose) Polymerase In Vitro

Characterization of an alternative BAK-binding site for BH3 peptides

Evaluation of the BH3-only Protein Puma as a Direct Bak Activator

ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status

A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice

COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A

The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer

Reactivating latent HIV with PKC agonists induces resistance to apoptosis and is associated with phosphorylation and activation of BCL2

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response

How does doxorubicin work?

Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization

Topoisomerases and cancer chemotherapy: recent advances and unanswered questions [version 1; peer review: 3 approved]

Eltrombopag directly activates BAK and induces apoptosis

ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance

DAGBagM: learning directed acyclic graphs of mixed variables with an application to identify protein biomarkers for treatment response in ovarian cancer

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes

Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma

Immunodetection of human topoisomerase I-DNA covalent complexes

Suchergebnisse filtern